ArticleFrontiers in artificial intelligence2026
A novel Weighted Exponential-Lindley distribution with Bayesian estimation under progressive Type-II censoring and a Bayesian-Calibrated Variational Autoencoder for survival prediction.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One-parameter lifetime models, such as the exponential and Lindley distributions, and two-parameter extensions such as the weighted Lindley distribution cannot separately control tail weight and dispersion, since a single shape parameter governs both. We address this with the Weighted Exponential-Lindley (WEL) distribution, a three-parameter model built by applying a length-biased weight to a mixture of exponential and Lindley components, with closed-form density, survival function, and an exact two-component gamma mixture representation. Using this representation and Glaser's failure-rate criterion, we prove that the WEL hazard rate is strictly increasing on its entire parameter space, with the scale parameter as its asymptotic level; the weight parameter then gives independent, tunable control over dispersion, skewness, and kurtosis are unavailable in the Lindley or weighted Lindley families. We develop maximum likelihood, method-of-moments, and Bayesian estimation under progressive Type-II censoring, validated through a Monte Carlo study across several parameter configurations and sample sizes, reporting bias, MSE, interval coverage, computation time, and convergence rates, including non-convergent method-of-moments runs rather than only successful ones. We then propose the Bayesian-Calibrated Variational Autoencoder Survival Model (BC-VAESM), whose decoder outputs individual, covariate-dependent WEL parameters, trained end-to-end via a censored negative log-likelihood. We evaluate both contributions on real, publicly available survival datasets, including censored clinical trial data and complete reliability/biological benchmarks, one chosen specifically to illustrate WEL's inability to represent bathtub hazards and one matching its increasing-hazard property. Fitting the censored datasets under an explicit right-censored likelihood, distinguished from the progressive Type-II scheme used in the Bayesian machinery, WEL is compared against an expanded set of competing one-, two-, and three-parameter lifetime models, including further weighted distributions. WEL is the best-fitting model on one dataset but is outperformed on others, and we report all outcomes without selective emphasis. In five-fold cross-validation, the BC-VAESM modestly exceeds a penalized Cox model and an otherwise identical Weibull-decoder autoencoder, though the improvement is not statistically significant at the sample size examined. Every estimate reported here comes from real, reproducible computation on real data. MSC 2020:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.